Notice of annual general meeting of Calliditas Therapeutics AB (publ) – April 28, 2023
The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual general meeting on Tuesday 30 May 2023 at Klara, Klarabergsviadukten 90, Stockholm, Sweden.
Notice of annual general meeting of Calliditas Therapeutics AB (publ) – April 28, 2023 Read More »
